TIPARP and cancer: In conclusion, further research into PARP7 substrates and how their function is altered upon PARP7-mediated MARylation or its loss in malignancy could help create better strategies for targeting and treatment of cancers such as breast, ovarian, lung, pancreatic cancer and glioma.